Navigation Links
JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals
Date:3/16/2012

MESA, Ariz., March 16, 2012 /PRNewswire/ -- On March 8, attorneys at the Arizona law firm of JacksonWhite filed a collective action lawsuit against Sunovion Pharmaceuticals for failure to pay its employees the overtime wages to which they are entitled under the Fair Labor Standards Act (FLSA). The Complaint was filed in the United States District Court for the District of Oregon on behalf of all Sunovion pharmaceutical reps employed in the U.S. from March 2009 until the present.

Michael Pruitt is lead counsel for the individual and collective plaintiffs. "This case is about seeing to it that Sunovion employees are fully compensated for the long hours it takes to meet Sunovion's demands," said Pruitt. Sunovion requires its employees to work well over forty hours per week, and it has never paid its employees overtime wages, despite the overtime requirement that is clearly defined and outlined by federal law. Sunovion's willful violation of this law could entitle Sunovion reps to damages of up to two times the amount of overtime wages that Sunovion should have paid them over the past three years.

Sunovion's policy of withholding overtime wages is by no means unique. Industry-wide, multi-billion dollar pharmaceutical companies have knowingly misclassified their pharmaceutical reps as exempt from the FLSA's overtime requirement. The tide seems to be turning, however, as reps have banded together en masse to assert their legal rights. In January 2012, for instance, a Federal Court in New York preliminarily approved a 99 million dollar settlement for Novartis reps that were unlawfully deprived of overtime wages. 

In addition to the Sunovion lawsuit, JacksonWhite has a collective action lawsuit against GlaxoSmithKline that is presently pending review at the U.S. Supreme Court. The attorneys working on the case are cautiously optimistic about its outcome, and they expect that a favorable decision by the justices could lead to a revolution in the way in which pharmaceutical reps are compensated. If the Supreme Court sides with reps in the Glaxo case, it is that much more likely that Sunovion reps will also prevail on their claim.

Importantly, Sunovion reps can only participate in this collective action lawsuit if they provide a written consent to join. And given that there is a statute of limitations in these types of cases, reps who delay are subject to losing damages to which they might otherwise be entitled. The attorneys at JacksonWhite are interested in speaking with Sunovion reps about opting in to this collective action. Reps who work for other companies might also be able to join a legal action, or file a new action against the company for which they work. For more information, contact JacksonWhite at 480-779-0993 or visit www.pharmaovertime.com.


'/>"/>
SOURCE Jackson White P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D
2. Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
3. Essentialis Files Two New Patent Applications for Investigational Compound DCCR
4. Bionovo Files Registration Statement for Offering of Convertible Preferred Stock and Warrants
5. ReBuilder (RBRM) Files Complaints Against Stock Traders
6. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
7. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
8. Department of Justice files consent decree of permanent injunction against Ranbaxy
9. Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes
10. Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
11. Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 7, 2017 Caris Life Sciences, a ... the promise of precision medicine, today announced results ... of its molecular profiling approach in guiding therapeutic ... profiling plus (CGP+) with Caris Molecular Intelligence ® ... a molecular level, leading to more therapeutic options ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Finn Mouseson”: ... take precedence in an average life. This mouse sets out on a journey that ... heart. “Finn Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe ... creation of published author, Brooks Rathell. , “We typically hear about the favor of ... financial favor of God. Not only does it exist, but it is meant for ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
(Date:9/19/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Swirl: A Wine Tasting Event series on Thursday, October 26, 2017. Hosted at ...
(Date:9/19/2017)... MD (PRWEB) , ... September 19, 2017 , ... ... the Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” ... for SPBA Members as it focused on best practices for third party administrators ...
Breaking Medicine News(10 mins):